Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2025

Accounting Policies [Abstract]

Schedule of Segment Reporting Information

The following table is representative of the significant expense categories regularly provided to the CODM

when managing the Company’s single reporting segment and includes a reconciliation to the consolidated

net loss shown in the condensed consolidated statements of operations and comprehensive loss for the

three and six months ended June 30, 2025 and 2024 (in thousands):

	Three Months Ended June 30,		Six Months Ended June 30,
	2025	2024	2025	2024
Revenue ................................................................	$43,424	$31,054	$80,629	$57,897
Less(1):
Cost of revenue ...............................................	10,646	7,215	19,910	14,635
Research and development expenses:
Research and development .....................	8,995	6,223	17,322	12,120
Regulatory and clinical ..............................	6,037	3,709	11,633	7,254
Selling, general and administrative expenses:
Sales ............................................................	18,485	17,406	35,438	32,962
Marketing .....................................................	4,481	2,952	9,163	5,852
General and administrative .......................	8,495	7,726	18,380	15,309
Loss from operations ...........................................	(13,715)	(14,177)	(31,217)	(30,235)
Other income (expense), net(2) .....................	4,578	(9,082)	(10,265)	(14,028)
Provision for income taxes ............................	(59)	(120)	(59)	(48)
Segment net loss .................................................	$(9,196)	$(23,379)	(41,541)	$(44,311)

(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.

(2)Other income (expense), net represents the consolidated amounts for interest income, interest expense, change in fair value of

common stock warrant liability, change in fair value of derivative liability and other income (expense), net as shown on the condensed

consolidated statements of operations and comprehensive loss.

Schedule of Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents and restricted cash to the total

shown in the condensed consolidated statements of cash flows (in thousands):

	June 30,
	2025	2024
Cash and cash equivalents ...............................................................................	$80,210	$75,370
Restricted cash ....................................................................................................	4,475	4,467
Total cash, cash equivalents and restricted cash ..........................................	$84,685	$79,837

Schedule of Restrictions on Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents and restricted cash to the total

shown in the condensed consolidated statements of cash flows (in thousands):

	June 30,
	2025	2024
Cash and cash equivalents ...............................................................................	$80,210	$75,370
Restricted cash ....................................................................................................	4,475	4,467
Total cash, cash equivalents and restricted cash ..........................................	$84,685	$79,837